1-8 of 8
Authors: Hsiang-Hsuan Michael Yu
Journal Article
SURG-26. HYDROCEPHALUS IN LEPTOMENINGEAL DISEASE: TANDEM OMMAYA RESERVOIR-SHUNT FOR INTRATHECAL CHEMOTHERAPY ADMINISTRATION Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v267, https://doi.org/10.1093/neuonc/noad179.1025
Published: 10 November 2023
Journal Article
RADT-07. CLINICAL OUTCOMES OF MELANOMA BRAIN METASTASES TREATED WITH NIVOLUMAB AND IPILIMUMAB ALONE VERSUS NIVOLUMAB AND IPILIMUMAB WITH STEREOTACTIC RADIOSURGERY Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v49, https://doi.org/10.1093/neuonc/noad179.0196
Published: 10 November 2023
Journal Article
CTIM-01. NIVOLUMAB AND STEREOTACTIC RADIOSURGERY (SRS) FOR PATIENTS WITH BREAST CANCER BRAIN METASTASES: LONG TERM RESULTS AND CELL FREE DNA (CFDNA) ASSESSMENT FROM A NON-RANDOMIZED, OPEN-LABEL, PHASE IB STUDY Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v60, https://doi.org/10.1093/neuonc/noad179.0241
Published: 10 November 2023
Journal Article
RADT-09. CLINICAL OUTCOMES OF FRACTIONATED STEREOTACTIC RADIOTHERAPY FOR INTACT AND POSTOPERATIVE RADIORESISTANT RENAL CELL CARCINOMA AND MELANOMA BRAIN METASTASES Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v50, https://doi.org/10.1093/neuonc/noad179.0198
Published: 10 November 2023
Journal Article
CTNI-04. PHASE I STUDY OF RADIATION THERAPY (RT) FOLLOWED BY INTRATHECAL (IT) TRASTUZUMAB/PERTUZUMAB IN THE MANAGEMENT OF HER2+ BREAST LEPTOMENINGEAL DISEASE (LMD) Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v73–v74, https://doi.org/10.1093/neuonc/noad179.0286
Published: 10 November 2023
Journal Article
MODL-06. THE GUT MICROBIOTA OF BRAIN TUMOR PATIENTS CAN IMPACT IMMUNOTHERAPY EFFICACY IN A PRECLINICAL MODEL OF GLIOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v299, https://doi.org/10.1093/neuonc/noad179.1157
Published: 10 November 2023
Journal Article
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study Free
Neuro-Oncology, Volume 23, Issue 4, April 2021, Pages 677–686, https://doi.org/10.1093/neuonc/noaa260
Published: 11 November 2020
Journal Article
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913 Free
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 666–673, https://doi.org/10.1093/neuonc/nox209
Published: 06 November 2017
